Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.

Source:http://linkedlifedata.com/resource/pubmed/id/10232603

Cancer Res. 1999 May 1 59 9 2159-66

Download in:

View as

General Info

PMID
10232603